Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: A randomized study
- 2 November 2017
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 44 (1) , 81-86
Abstract
Aim: We aimed to assess the use of metformin (MTF) in the prevention of gestational diabetes mellitus (GDM) in patients with pregestational insulin resistance (PIR).Methods: A double blind, multicenter, randomized trial was carried out in patients with a history of PIR and pregestational MTF treatment. Groups were allocated either to MTF 1700 mg/day or placebo. Patients were recruited between 12+0 and 15+6 gestational weeks, and treatment was extended until week 36. A multiple logistic regression analysis was applied to determine the relation between the use of metformin and the development of GDM.Results: One hundred and forty one patients were randomized (68 patients in the MTF group and 73 in the placebo group). A total of 30 patients withdrew from the study during follow‐up. Administration of MTF was not associated with a decrease in the incidence of GDM as compared to placebo (37.5% vs 25.4%, respectively; P = 0.2). Moreover, MTF administration was associated with a significant increase in drug intolerance as compared to placebo (14.3% vs 1.8%, respectively; P = 0.02).Conclusion: The use of MTF is not effective in prevention of GDM in populations with PIR. The use of MTF shows a significantly higher frequency of drug intolerance than placebo.Keywords
This publication has 24 references indexed in Scilit:
- Metformin versus Placebo in Obese Pregnant Women without Diabetes MellitusNew England Journal of Medicine, 2016
- Effect of metformin on early pregnancy loss in women with polycystic ovary syndromeTaiwanese Journal of Obstetrics and Gynecology, 2015
- Effect of Metformin Intervention during Pregnancy on the Gestational Diabetes Mellitus in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-AnalysisJournal of Diabetes Research, 2014
- Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic reviewMetabolism, 2013
- Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overviewActa Obstetricia et Gynecologica Scandinavica, 2012
- The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complicationsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndromeFertility and Sterility, 2008
- Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndromeFertility and Sterility, 2002
- Hyperinsulinemia in a normal population as a predictor of non—insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The barilla factory revisitedMetabolism, 1999
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985